BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17934924)

  • 1. Changes of cholinesterase activities in the rat blood and brain after sarin intoxication pretreated with butyrylcholinesterase.
    Bajgar J; Bartosova L; Kuca K; Jun D; Fusek J
    Drug Chem Toxicol; 2007; 30(4):351-9. PubMed ID: 17934924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine butyrylcholinesterase protects rats against inhalation exposure to sublethal sarin concentrations.
    Bajgar J; Bartosova L; Fusek J; Jun D; Kuca K
    Arh Hig Rada Toksikol; 2006 Dec; 57(4):391-5. PubMed ID: 17265678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of equine butyrylcholinesterase in inhalation intoxication of rats with sarin: determination of blood and brain cholinesterase activities.
    Sevelová L; Bajgar J; Saxena A; Doctor BP
    Inhal Toxicol; 2004 Jul; 16(8):531-6. PubMed ID: 15204744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasmatic levels of sarin and cholinesterase inhibition in rats exposed to sarin vapors.
    Sevelová L; Bajgar J; Bielavská M
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S80-2. PubMed ID: 15141989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential mRNA expression of acetylcholinesterase in the central nervous system of rats with acute and chronic exposure of sarin & physostigmine.
    Bansal I; Waghmare CK; Anand T; Gupta AK; Bhattacharya BK
    J Appl Toxicol; 2009 Jul; 29(5):386-94. PubMed ID: 19283689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood and bronchoalveolar lavage fluid acetylcholinesterase levels following microinstillation inhalation exposure to sarin in Guinea pigs.
    Che MM; Conti M; Boylan M; Sciuto AM; Gordon RK; Nambiar MP
    Inhal Toxicol; 2008 Jul; 20(9):821-8. PubMed ID: 18645722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of acetylcholinesterase activity after long-term exposure to sarin vapors in rats.
    Bartosova-Sevelova L; Bajgar J
    Hum Exp Toxicol; 2005 Jul; 24(7):363-7. PubMed ID: 16119250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte and plasma cholinesterase activity in male and female rhesus monkeys before and after exposure to sarin.
    Woodard CL; Calamaio CA; Kaminskis A; Anderson DR; Harris LW; Martin DG
    Fundam Appl Toxicol; 1994 Oct; 23(3):342-7. PubMed ID: 7835534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of human serum butyrylcholinesterase against sarin vapor.
    Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
    Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with endotracheal therapeutics after sarin microinstillation inhalation exposure increases blood cholinesterase levels in guinea pigs.
    Che MM; Song J; Oguntayo S; Doctor BP; Rezk P; Perkins MW; Sciuto AM; Nambiar MP
    Toxicol Mech Methods; 2012 May; 22(4):250-9. PubMed ID: 22145985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute sarin exposure causes differential regulation of choline acetyltransferase, acetylcholinesterase, and acetylcholine receptors in the central nervous system of the rat.
    Khan WA; Dechkovskaia AM; Herrick EA; Jones KH; Abou-Donia MB
    Toxicol Sci; 2000 Sep; 57(1):112-20. PubMed ID: 10966517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in Göttingen minipigs exposed to sarin vapor.
    Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
    Biochem Pharmacol; 2011 Dec; 82(12):1984-93. PubMed ID: 21968035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-exposure treatment with nasal atropine methyl bromide protects against microinstillation inhalation exposure to sarin in guinea pigs.
    Che MM; Conti M; Chanda S; Boylan M; Sabnekar P; Rezk P; Amari E; Sciuto AM; Gordon RK; Doctor BP; Nambiar MP
    Toxicol Appl Pharmacol; 2009 Sep; 239(3):251-7. PubMed ID: 19523969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of rats to low levels of sarin.
    Henderson RF; Barr EB; Blackwell WB; Clark CR; Conn CA; Kalra R; March TH; Sopori ML; Tesfaigzi Y; Ménache MG; Mash DC
    Toxicol Appl Pharmacol; 2002 Oct; 184(2):67-76. PubMed ID: 12408950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats.
    Mioduszewski R; Manthei J; Way R; Burnett D; Gaviola B; Muse W; Thomson S; Sommerville D; Crosier R
    Toxicol Sci; 2002 Apr; 66(2):176-84. PubMed ID: 11896284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model.
    Ashani Y; Pistinner S
    Toxicol Sci; 2004 Feb; 77(2):358-67. PubMed ID: 14600276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cholinergic and neuromuscular toxicity following acute exposure to sarin and VX in rat.
    Gupta RC; Patterson GT; Dettbarn WD
    Fundam Appl Toxicol; 1991 Apr; 16(3):449-58. PubMed ID: 1855618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: dose-response relationships.
    Abdel-Rahman A; Shetty AK; Abou-Donia MB
    Neuroscience; 2002; 113(3):721-41. PubMed ID: 12150792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs.
    Valiyaveettil M; Alamneh Y; Rezk P; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
    Toxicol Lett; 2011 May; 202(3):203-8. PubMed ID: 21329748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical effects of low level exposure to soman vapour.
    Bajgar J; Sevelová L; Krejcová G; Fusek J; Vachek J; Kassa J; Herink J; de Jong LP; Benschop H
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S4-7. PubMed ID: 15141961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.